Low-Dose Interleukin-2 Altered Gut Microbiota and Ameliorated Collagen-Induced Arthritis

PURPOSE: Low-dose interleukin-2 (ld-IL-2) has been shown to regulate the balance between effector T and regulatory T (Treg) cells and has been used in several clinical trials to treat autoimmune diseases including rheumatoid arthritis (RA). In this study, we investigated the effects of ld-IL-2 on co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Li, Xuefei, Su, Rui, Wu, Ruihe, Niu, Hong-Qing, Luo, Jing, Gao, Chong, Li, Xiaofeng, Wang, Caihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887675/
https://www.ncbi.nlm.nih.gov/pubmed/35241924
http://dx.doi.org/10.2147/JIR.S344393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887675/
https://www.ncbi.nlm.nih.gov/pubmed/35241924
http://dx.doi.org/10.2147/JIR.S344393

Ejemplares similares